Purtskhvanidze Konstantine, Saeger Mark, Treumer Felix, Roider Johann, Nölle Bernhard
Department of Ophthalmology, University Medical Center Schleswig-Holstein, Arnold-Heller Strasse 3, Haus 25, D-24105, Kiel, Germany.
BMC Ophthalmol. 2019 Jan 10;19(1):14. doi: 10.1186/s12886-019-1027-z.
To evaluate long-term results of eyes with glaucoma drainage device (GDD).
We retrospectively reviewed medical records of all patients who underwent GDD placement at our institution between 2001 and 2014. A total of 110 eyes of 90 patients were studied. Glaucoma outcome was assessed by postoperative intraocular pressure (IOP), number of medications, and need for further glaucoma surgery. Surgical procedures before and during the study period, and their complications were evaluated.
The mean follow-up was 78.3 ± 44.0 months. The mean preoperative intraocular pressure was 30.8 ± 6.9 mmHg with 3.5 ± 1.1 glaucoma medications. At last postoperative follow-up, the mean IOP decreased to 14.3 ± 5.4 mmHg with 1.6 ± 1.5 glaucoma medications. GDD implantation successfully controlled glaucoma in 86, 85, 81, 78, 79, 76 and 73% of eyes at 1, 2, 3, 4, 5, 7 and 10 years, respectively. At last follow-up IOP was successfully controlled in 67% of eyes. Clinical complications occurred in 56.4% of eyes during the follow-up period.
A glaucoma drainage device can successfully control intractable glaucoma even after a very long period of time.
评估青光眼引流装置（GDD）植入眼的长期效果。
我们回顾性分析了2001年至2014年间在我院接受GDD植入手术的所有患者的病历。共研究了90例患者的110只眼。通过术后眼压（IOP）、药物使用数量以及是否需要进一步的青光眼手术来评估青光眼治疗效果。对研究期间手术前后的操作及其并发症进行了评估。
平均随访时间为78.3±44.0个月。术前平均眼压为30.8±6.9 mmHg，使用3.5±1.1种青光眼药物。术后最后一次随访时，平均眼压降至14.3±5.4 mmHg，使用1.6±1.5种青光眼药物。GDD植入分别在1、2、3、4、5、7和10年时成功控制青光眼的眼数比例为86%、85%、81%、78%、79%、76%和73%。在最后一次随访时，67%的眼眼压得到成功控制。随访期间56.4%的眼出现临床并发症。
即使经过很长一段时间，青光眼引流装置仍能成功控制难治性青光眼。
